Kangqin Pharmaceutical (01681): Yishen Huashi granules approved as second-class protected Chinese medicine variety.

Zhtng Cijng APP news, Koncen Pharmaceutical (01681) announced that on April 28, 2025, the National Medical Products Administration issued the "Chinese Medicine Protected Variety Announcement (No. 25) (2025 No. 45)", in which the group's product Yishen Huashi Granules has been approved as a second-level protected variety according to the "Chinese Medicine Variety Protection Regulations". The company's wholly-owned subsidiary, Guangzhou Koncen Pharmaceutical Co., Ltd. (Guangzhou Koncen), was granted the "Chinese Medicine Protected Variety Certificate" (the certificate), Certificate No.: (2025) Guoyao Zhongbaozi No.009.